eMedicals Healthtech GmbH
Founded in 2020, eMedicals Healthtech develops a plant biochemical platform for novel therapeutics and pioneers AI analytics and biomarkers for Chronic Kidney Disease and Cardiometabolic Diseases.
Classification
Profile
Funding
Funding details not yet available.
Signals
Delivering innovative food-based drug delivery systems that use everyday foods to improve medication efficacy and patient adherence for nutrition-sensitive diseases.
Patients with chronic kidney disease, type 2 diabetes, and cardiovascular disease, alongside healthcare providers and industry partners in life sciences.
SaaS subscription fees - tiered per-user pricing for clinicians, per-patient pricing for insurers · Data-licensing fees - anonymised RWD sold to pharma/biotech for research & post-marketing surveillance · Implementation & integration services - one-off fees for EHR integration, training, and customization
Direct B2B sales force - targeting hospital networks, dialysis centres, and insurer procurement teams · Strategic partnerships - with electronic health record (EHR) vendors and laboratory services for data integration · Clinical conferences & webinars - thought-leadership to reach clinicians and payers (e.g., guest lecture at University of Marburg
EHR & health-IT vendors - for seamless data exchange (e.g., SAP Health, Cerner) · Laboratories & genomics providers - to supply nutrigenomic data · Academic hospitals & research institutes - for clinical validation (e.g., University Hospital Frankfurt)
R&D for biochemical platforms and next-generation AI solutions, plus operational costs for company management in Frankfurt.
Proprietary biochemical platform for drug delivery, AI technologies for nutrition-sensitive diseases, and specialized team expertise in life sciences and healthtech.
Developing novel therapeutics using nutrigenomics and AI, and advancing food-based active pharmaceutical ingredient delivery systems.
High-touch onboarding - dedicated implementation specialists for hospitals/insurers · Subscription-based support - 24/7 technical help desk and periodic clinical training webinars · Data-sharing agreements - transparent consent management to build trust with patients and pharma partners
Competes at the intersection of life sciences and healthtech by combining food-based delivery with AI for chronic disease management.
Poor medication adherence and ineffective progression control for chronic nutrition-sensitive diseases like CKD, T2D, and CVD.
- Validate the outcome claim - Run a controlled pilot with at least one insurer to quantify reductions in dialysis initiation; use results
- Regulatory status: Has the kidi platform obtained any medical-device certification (CE-Mark, FDA 510(k))?
No investors recorded yet.